Literature DB >> 7388247

The natural history of schizophrenia in the long term.

L Ciompi.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 7388247     DOI： 10.1192/bjp.136.5.413

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  36 in total

Review 1.  Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning.

Authors:  B E Seaton; G Goldstein; D N Allen
Journal:  Neuropsychol Rev       Date:  2001-03       Impact factor: 7.444

2.  Renaming schizophrenia: a Japanese perspective.

Authors:  Mitsumoto Sato
Journal:  World Psychiatry       Date:  2006-02       Impact factor: 49.548

Review 3.  Antipsychotic medication for elderly people with schizophrenia.

Authors:  R G Marriott; W Neil; S Waddingham
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

4.  Gender differences in the prediction of 5-year outcome in first episode psychosis.

Authors:  Maria Mattsson; Lena Flyckt; Gunnar Edman; Håkan Nyman; Johan Cullberg; Yvonne Forsell
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

5.  The fallacy of the medical model and the dangers of psychotropic drugs as a mode of treatment for mental disorders.

Authors:  V D Sanua
Journal:  J Prim Prev       Date:  1996-09

Review 6.  The effects of early and sustained intervention on the long-term morbidity of schizophrenia.

Authors:  R J Wyatt; I D Henter
Journal:  J Psychiatr Res       Date:  1998 May-Aug       Impact factor: 4.791

7.  Management of schizophrenia : an update.

Authors:  P Kulhara
Journal:  Indian J Psychiatry       Date:  1998-04       Impact factor: 1.759

8.  The Illness Management and Recovery program: rationale, development, and preliminary findings.

Authors:  Kim T Mueser; Piper S Meyer; David L Penn; Richard Clancy; Donna M Clancy; Michelle P Salyers
Journal:  Schizophr Bull       Date:  2006-08-09       Impact factor: 9.306

9.  Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.

Authors:  A Fitton; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

Review 10.  The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.

Authors:  Marc De Hert; Jan Sermon; Paul Geerts; Kristof Vansteelandt; Joseph Peuskens; Johan Detraux
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.